- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT00373425
A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors (RADIANT)
A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Single-agent Tarceva® (Erlotinib) Following Complete Tumor Resection With or Without Adjuvant Chemotherapy in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma Who Have EGFR-positive Tumors
연구 개요
상세 설명
연구 유형
등록 (실제)
단계
- 3단계
연락처 및 위치
연구 장소
-
-
-
Athens, 그리스, 15562
- IASO General Hospital of Athens
-
Thessaloniki, 그리스, 54603
- "Papageorgiou" General Hospital of Thessaloniki
-
Thessaloniki, 그리스, 57010
- "G. Papanikolaou" General Hospital of Thessaloniki
-
-
-
-
-
Changhua, 대만, 500-06
- Changhua Christian Hospital
-
Kaohsiung, 대만, 833
- Chang Gung Medical Foundation
-
Taichung, 대만, 404
- China Medical University Hospital
-
Taichung, 대만, 402
- Chung Shan Medical University Hospital
-
Taichung, 대만, 407
- Taichung Veterans General Hospital
-
Taipei, 대만, 112
- Taipei Veterans General Hospital
-
Taoyuan, 대만, 333
- Chang Gung Memorial Hospital
-
-
-
-
-
Gyeonggi-Do, 대한민국, 442-723
- Saint Vincent's Hospital
-
Incheon, 대한민국, 405-760
- Gachon Medical School Ghil Medical Center
-
Seoul, 대한민국, 138-736
- Asan Medical Center
-
Seoul, 대한민국, 110-744
- Seoul National University Hospital
-
Seoul, 대한민국, 120-752
- Severance Hospital, Yonsei Univ. College of Medicine
-
-
-
-
-
Bad Berka, 독일, 99437
- Zentralklinik Bad Berka
-
Berlin, 독일, 14165
- Helios Klinikum Emil von Behring GmbH
-
Bochum, 독일, 44791
- Augusta-Krankenanstalt Bochum
-
Coswig, 독일, 01640
- Fachkrankenhaus Coswig
-
Essen, 독일, 45122
- Universitaetsklinikum Essen
-
Frankfurt/Main, 독일, 60488
- Krankenhaus Nordwest
-
Freiburg, 독일, 79106
- Universitatsklinikum Freiburg
-
Großhansdorf, 독일, 22927
- LungenClinic Grosshansdorf
-
Göttingen, 독일, 37075
- Universitätsklinikum Göttingen
-
Halle (Saale), 독일, 06120
- Städtisches Krankenhaus Martha-Maria, Halle-Dölau
-
Hamburg, 독일, 21075
- Asklepios Klinik Harburg
-
Heidelberg, 독일, 69126
- Thoraxklinik Heidelberg
-
Hemer, 독일, 58675
- Lungenklink Hemer des Deutschen Gemeinschafts-Diakonieverbandes GmbH
-
Karlsruhe, 독일, 76137
- St. Vincentius-Kliniken Karlsruhe
-
Lübeck, 독일, 23538
- Universitaetsklinikum Schleswig-Holstein
-
Mainz, 독일, 55131
- Universitätsklinikum Mainz
-
Muenchen-Gauting, 독일, 82131
- Asklepios Klinikum Gauting
-
Oldenburg, 독일, 26121
- Pius Hospital Oldenburg
-
Villingen-Schwenningen, 독일, 78050
- Schwarzwald-Baar Klinikum
-
-
-
-
-
Arkhangelsk, 러시아 연방, 163045
- State Healthcare Institution "Arkhangelsk Regional Clinical Oncology Dispensary"
-
Kemerovo, 러시아 연방, 650036
- State Healthcare Institution "Regional Clinical Oncology Dispensary"
-
Krasnodar, 러시아 연방, 350086
- State Healthcare Institution "Region Clinical Hospital # 1 n.a. professor S.V. Ochapovsky"
-
Moscow, 러시아 연방, 105229
- State Institution "Central Military Clinical Hospital n.a. academician N.N. Burdenko under the Ministry of Defense of Russia"
-
Moscow, 러시아 연방, 115478
- Institution of the RAMS "Russian Oncology Scientific Centre n.a. N.N. Blokhin under the Russian Academy of Medical Sciences"
-
Saint-Petersburg, 러시아 연방, 197022
- State Educational Institution of Higher Professional Education "Saint-Petersburg State Medical University n.a. ac. I.P. Pavlov of the Ministry of Healthcare and Social Development of the Russian Federation"
-
Saint-Petersburg, 러시아 연방, 197758
- Federal State Institution "Petrov Scientific Research Institute of Oncology of Rosmedtechnology"
-
Saint-Petersburg, 러시아 연방, 198255
- Saint-Petersburg State Healthcare Institution "City Clinical Oncology Dispensary"
-
Tomsk, 러시아 연방, 634050
- Regional State Budget Healthcare Instiution"Tomsk Regional Oncology Dispensary"
-
Yaroslavl, 러시아 연방, 150040
- State Healthcare Institution of Yaroslavl Region "Regional Clinical Oncology Hospital"
-
-
-
-
-
Bucuresti, 루마니아, 022328
- Institutul Oncologic Al. Trestioreanu Sectia Oncologie Medicala II
-
Bucuresti, 루마니아, 022328
- Institutul Oncologic Al. Trestioreanu
-
Cluj-Napoca, 루마니아, 400015
- Institutul Oncologic Prof. Dr. Ion Chiricuta
-
Iasi, 루마니아, 700106
- Centrul de Oncologie Medicala
-
Sibiu, 루마니아, 550245
- Spitalul Clinic Judetean Sibiu
-
-
Bihor
-
Oradea, Bihor, 루마니아, 410032
- Spitalui Clinic Judetean de Urgenta, Sectia de Oncologie
-
-
Dolj
-
Craiova, Dolj, 루마니아, 200535
- Oncoloab SRL
-
-
-
-
Alabama
-
Birmingham, Alabama, 미국, 35294
- University of Alabama at Birmingham
-
-
Arizona
-
Tucson, Arizona, 미국, 85724
- Arizona Cancer Center
-
-
Arkansas
-
Little Rock, Arkansas, 미국, 72205
- University of Arkansas for Medical Science
-
-
California
-
Beverly Hills, California, 미국, 90211
- Tower Cancer Research Foundation
-
Duarte, California, 미국, 91010
- City of Hope Nat'l Medical Center
-
Loma Linda, California, 미국, 92354
- Loma Linda University Medical Center
-
Los Angeles, California, 미국, 90048
- Cedars-Sinai Medical Center
-
Los Angeles, California, 미국, 90033
- USC/ Norris Comprehensive Cancer Center
-
Newport Beach, California, 미국, 92658
- Hoag Memorial Hospital Presbyterian
-
Palm Springs, California, 미국, 92262
- Comprehensive Cancer Center at Desert Regional Medical Center
-
Pleasant Hill, California, 미국, 94523
- Bay Area Cancer Research Group, LLC
-
San Francisco, California, 미국, 94143-1770
- University of California, San Francisco Comprehensive Cancer Center
-
South Pasadena, California, 미국, 91030
- City of Hope Medical Group (COHMG)
-
-
Colorado
-
Aurora, Colorado, 미국, 80045
- University Of Colorado Hospital
-
Aurora, Colorado, 미국, 80012
- Rocky Mountain Cancer Center- Aurora
-
Boulder, Colorado, 미국, 80303
- Rocky Mountain Cancer Centers-Boulder
-
Colorado Springs, Colorado, 미국, 80907
- Rocky Mountain Cancer Center
-
Colorado Springs, Colorado, 미국, 80907
- Penrose St. Francis Health Services
-
Colorado Springs, Colorado, 미국, 80909
- Rocky Mountain Cancer Center
-
Denver, Colorado, 미국, 80218
- Rocky Mountain Cancer Center-Midtown
-
Denver, Colorado, 미국, 80220
- Rocky Mountain Cancer Centers- Rose
-
Lakewood, Colorado, 미국, 80228
- Rocky Mountain Cancer Centers
-
Littleton, Colorado, 미국, 80120-4413
- Rocky Mountain Cancer Centers-Littleton
-
Lone Tree, Colorado, 미국, 80124
- Rocky Mountain Cancer Center-Sky Ridge
-
Longmont, Colorado, 미국, 80501
- Rocky Mountain Cancer Centers-Longmont
-
Parker, Colorado, 미국, 80138
- Rocky Mountain Cancer Center-Parker
-
Thornton, Colorado, 미국, 80260
- Rocky Mountain Cancer Centers
-
-
Connecticut
-
New Haven, Connecticut, 미국, 06520
- Yale University
-
Sharon, Connecticut, 미국, 06069
- Smilow Cancer Hospital Care Center
-
Stamford, Connecticut, 미국, 06902
- Hematology Oncology, P.C.
-
Torrington, Connecticut, 미국, 06790
- Smilow Cancer Hospital Care Center
-
-
Florida
-
Hudson, Florida, 미국, 34667
- Florida Cancer Institute-New Hope
-
Jacksonville, Florida, 미국, 32204
- Cancer Specialists of North Florida
-
Jacksonville, Florida, 미국, 32216
- Cancer Specialists of North Florida
-
Lakeland, Florida, 미국, 33805
- Watson Clinic LLP
-
Miami, Florida, 미국, 33176
- Advanced Medical Specialties
-
New Port Richey, Florida, 미국, 34655
- Florida Cancer Institute- New Hope
-
Orlando, Florida, 미국, 32806
- Florida Cancer Specialists
-
Port St. Lucie, Florida, 미국, 34952
- Hematology Oncology Associates of the Treasure Coast
-
-
Georgia
-
Atlanta, Georgia, 미국, 30318
- Peachtree Hematology-Oncology Consultants, P.C.
-
Macon, Georgia, 미국, 31201
- Central Georgia Cancer Care, PC
-
Marietta, Georgia, 미국, 30060
- Northwest Georgia Oncology Centers, PC
-
-
Idaho
-
Boise, Idaho, 미국, 83712
- Mountain States Tumor Institute
-
Meridian, Idaho, 미국, 83642
- Mountain States Tumor Institute
-
Post Falls, Idaho, 미국, 83854
- Kootenai Cancer Center
-
Twin Falls, Idaho, 미국, 83301
- Mountain States Tumor Institute
-
-
Illinois
-
Chicago, Illinois, 미국, 60612
- Rush University Medical Center
-
Chicago, Illinois, 미국, 60637
- University of Chicago, Section of Hematology/Oncology
-
Joliet, Illinois, 미국, 60435
- Joliet Oncology Hematology Assoc., LTD
-
Maywood, Illinois, 미국, 60153
- Loyola University Medical Center
-
-
Indiana
-
Carmel, Indiana, 미국, 46032
- Indiana University Health
-
Fishers, Indiana, 미국, 46037
- Indiana University Health
-
Greenfield, Indiana, 미국, 46140
- Indiana University Health
-
Indianapolis, Indiana, 미국, 46219
- Indiana University Health
-
Indianapolis, Indiana, 미국, 46227
- Indiana University Health
-
-
Kansas
-
Westwood, Kansas, 미국, 66205
- University of Kansas Medical Center
-
-
Kentucky
-
Louisville, Kentucky, 미국, 40202
- Norton Healthcare, Inc.
-
-
Louisiana
-
Houma, Louisiana, 미국, 70363
- Leonard J. Chabert Medical Center
-
-
Maine
-
Brewer, Maine, 미국, 04412
- Cancer Care of Maine
-
-
Maryland
-
Baltimore, Maryland, 미국, 21204
- Greater Baltimore Medical Center
-
Towson, Maryland, 미국, 21204
- St. Joseph Medical Center's Cancer Institute
-
-
Massachusetts
-
Boston, Massachusetts, 미국, 02135
- Caritas St. Elizabeth's Medical Center
-
-
Michigan
-
Ann Arbor, Michigan, 미국, 48106
- St. Joseph Mercy Hospital
-
-
Minnesota
-
Burnsville, Minnesota, 미국, 55337
- Minnesota Oncology Hematology, P.A.
-
Edina, Minnesota, 미국, 55435-2150
- Minnesota Oncology Hematology, P.A.
-
Maplewood, Minnesota, 미국, 55109
- Minnesota Oncology Hematology, P.A.
-
Minneapolis, Minnesota, 미국, 55404
- Minnesota Oncology Hematology, P.A.
-
St. Paul, Minnesota, 미국, 55102-2389
- Minnesota Oncology Hematology
-
Woodbury, Minnesota, 미국, 55125
- Minnesota Oncology Hematology, P.A.
-
-
Missouri
-
Columbia, Missouri, 미국, 65201
- Missouri Cancer Associates
-
St. Joseph, Missouri, 미국, 64507
- Heartland Regional Medical Center d/b/a Heartland Clinic
-
-
Nebraska
-
Grand Island, Nebraska, 미국, 68803
- St. Francis Cancer Treatment Center
-
Omaha, Nebraska, 미국, 68114
- Nebraska Methodist Hospital
-
-
Nevada
-
Henderson, Nevada, 미국, 89052
- Comprehensive Cancer Centers of Nevada
-
Las Vegas, Nevada, 미국, 89148
- Comprehensive Cancer Centers of Nevada
-
Las Vegas, Nevada, 미국, 89128
- Comprehensive Cancer Centers of Nevada
-
Las Vegas, Nevada, 미국, 89169
- Comprehensive Cancer Centers of Nevada
-
-
New Hampshire
-
Concord, New Hampshire, 미국, 03301
- NH Oncology-Hematology PA (Co)
-
Hooksett, New Hampshire, 미국, 03106
- NH Oncology-Hematology PA
-
Lebanon, New Hampshire, 미국, 03756
- Dartmouth-Hitchcock Medical Center
-
-
New Jersey
-
Hackensack, New Jersey, 미국, 07601
- Hackensack University Medical Center
-
-
New Mexico
-
Albuquerque, New Mexico, 미국, 87131
- University of New Mexico Health Science Center
-
Santa Fe, New Mexico, 미국, 87505
- CHRISTUS St. Vincent Regional Cancer Center
-
-
New York
-
Brockport, New York, 미국, 14420
- Interlakes Oncology Hematology, PC
-
Bronx, New York, 미국, 10467
- Montefiore Medical Center
-
Canadaigua, New York, 미국, 14424
- Interlakes Oncology Hematology, PC
-
Geneva, New York, 미국, 14456
- Interlakes Oncology Hematology, PC
-
New Rochelle, New York, 미국, 10801
- Advanced Oncology Associates
-
New York, New York, 미국, 10065
- The New York Presbyterian-Weill Medical College of Cornell University
-
Rochester, New York, 미국, 14623
- Interlakes Oncology Hematology, PC
-
Rochester, New York, 미국, 14626
- Interlakes Oncology Hematology, PC
-
Stony Brook, New York, 미국, 11794
- Stony Brook University Medical Center
-
-
North Carolina
-
Cary, North Carolina, 미국, 27511
- Raleigh Hematology Oncology Associates d/b/a Cancer Center of North Carolina
-
Hickory, North Carolina, 미국, 28602
- Carolina Oncology Specialists PA
-
Raleigh, North Carolina, 미국, 27607
- Raleigh Hematology Oncology Associates
-
Raleigh, North Carolina, 미국, 27609
- Raleigh Hematology Oncology Associates
-
-
Ohio
-
Canton, Ohio, 미국, 44710
- Aultman Hospital/ North Canton Medical Foundation
-
Cleveland, Ohio, 미국, 44106
- University Hopsitals of Cleveland
-
Columbus, Ohio, 미국, 43228
- Hematology Oncology Consultants Inc.
-
-
Oregon
-
Portland, Oregon, 미국, 97213
- Northwest Cancer Specialists, PC
-
Portland, Oregon, 미국, 97225
- Northwest Cancer Specialists, PC
-
Portland, Oregon, 미국, 97227
- Northwest Cancer Specialists, PC
-
Portland, Oregon, 미국, 97213
- Earle A Chiles Research Institute
-
Tualatin, Oregon, 미국, 97062
- Northwest Cancer Specialists, PC
-
-
Pennsylvania
-
Bethlehem, Pennsylvania, 미국, 18015
- Cancer Care Associates - Medical Oncology
-
Philadelphia, Pennsylvania, 미국, 19104
- The Hospital of the University of Pennsylvania
-
Pittsburg, Pennsylvania, 미국, 15212
- Allegheny General Hospital
-
-
South Carolina
-
Columbia, South Carolina, 미국, 29210
- South Carolina Oncology Assoc., PA
-
Easley, South Carolina, 미국, 29640
- Cancer Centers of the Carolinas
-
Greenville, South Carolina, 미국, 29605
- Cancer Centers of the Carolinas
-
Greenville, South Carolina, 미국, 29615
- Cancer Centers of the Carolinas
-
Seneca, South Carolina, 미국, 29672
- Cancer Centers of the Carolinas, Seneca
-
Spartanburg, South Carolina, 미국, 29307
- Cancer Centers of the Carolinas
-
-
Tennessee
-
Cookeville, Tennessee, 미국, 38501
- Cookeville Regional Medical Center
-
Germantown, Tennessee, 미국, 38138
- Bostin Baskin Cancer Foundation
-
Knoxville, Tennessee, 미국, 37909
- Tennessee Cancer Specialists
-
Memphis, Tennessee, 미국, 38120
- West Clinic
-
Memphis, Tennessee, 미국, 38119
- Family Cancer Center Foundation, Inc.
-
Memphis, Tennessee, 미국, 38104
- Bostin Baskin Cancer Foundation
-
Nashville, Tennessee, 미국, 37203
- Sarah Cannon Cancer Center
-
Nashville, Tennessee, 미국, 37203
- Sarah Cannon Research Institute
-
-
Texas
-
Amarillo, Texas, 미국, 79106
- Texas Oncology, P.A. - Amarillo
-
Beaumont, Texas, 미국, 77702-1449
- Texas Oncology Beaumont
-
Dallas, Texas, 미국, 75246
- Baylor Charles A Sammons Cancer Center
-
Dallas, Texas, 미국, 75230-2510
- Texas Oncology Texas Cancer Center at Medical City
-
Flower Mound, Texas, 미국, 75028
- Texas Oncology - Flower Mound
-
Fort Worth, Texas, 미국, 76132
- Texas Oncology Southwest Forth Worth
-
Ft. Worth, Texas, 미국, 76104
- Texas Oncology, Fort Worth
-
Garland, Texas, 미국, 75042-5788
- Texas Oncology, Garland
-
New Braunfels, Texas, 미국, 78131
- Cancer Care Centers of South Texas - HOAST
-
Paris, Texas, 미국, 75460-5004
- Texas Oncology - Paris
-
Plano, Texas, 미국, 75075-7787
- Texas Oncology - Plano East
-
San Antonio, Texas, 미국, 78229
- Cancer Care Centers of South Texas-HOAST
-
Tyler, Texas, 미국, 75702
- Texas Oncology -Tyler
-
Waco, Texas, 미국, 76712
- Texas Oncology Cancer Care and Research Center
-
-
Virginia
-
Christiansburg, Virginia, 미국, 24073
- Onc and Hem Associates of SW VA, Inc. d/b/a Blue Ridge Cancer Care
-
Christiansburg, Virginia, 미국, 24073
- Onc and Hem Associates of SW VA, Inc.
-
Hampton, Virginia, 미국, 23666
- Virginia Oncology Associates
-
Newport News, Virginia, 미국, 23606
- Virginia Oncology Associates
-
Norfolk, Virginia, 미국, 23502
- Virginia Oncology Associates
-
Roanoke, Virginia, 미국, 24014
- Onc and Hem Associates of SW VA, Inc. d/b/a Blue Ridge Cancer Care
-
Salem, Virginia, 미국, 24153
- Onc and Hem Assoc of SW VA, Inc d/b/a Blue Ridge Cancer Care
-
Wytheville, Virginia, 미국, 24382
- Onc and Hem Associates of SW VA, Inc. d/b/a Blue Ridge Cancer Care
-
-
Washington
-
Seattle, Washington, 미국, 98109
- Univ. of Washington/ Seattle Cancer Care Alliance
-
Spokane, Washington, 미국, 99218
- Cancer Care Northwest-North
-
Spokane, Washington, 미국, 99202
- Cancer Care Northwest
-
Spokane Valley, Washington, 미국, 99216
- Cancer Care Northwest-Valley
-
Vancouver, Washington, 미국, 98684
- Northwest Cancer Specialists, P.C.
-
Vancouver, Washington, 미국, 98686
- Northwest Cancer Specialist, P.C.
-
-
-
-
-
Brussels, 벨기에, 1200
- Cliniques universitaires Saint-Luc
-
Brussels, 벨기에, 1070
- Hopital Erasme
-
Charleroi, 벨기에, 6000
- Le Grand Hôpital de Charleroi
-
La Louvière, 벨기에, 7100
- Centre Hospitalier Jolimont-Lobbes
-
-
-
-
-
Madrid, 스페인, 28041
- Hospital Universitario 12 de Octubre
-
Madrid, 스페인, 28046
- Hospital Universitario La Paz
-
Madrid, 스페인, 28033
- Hospital Oncologico MD Anderson
-
Málaga, 스페인, 29010
- Hospital Carlos Haya
-
Málaga, 스페인, 29010
- Hospital Clínico Virgen de la Victoria
-
Pamplona, 스페인, 31008
- Clinica Universitaria de Navarra
-
Santander, 스페인, 39008
- Hospital Universitario Marqués de Valdecilla
-
Sevilla, 스페인, 41700
- Hospital Universitario de Valme
-
Toledo, 스페인, 45004
- Hospital Virgen de la Salud de Toledo
-
Valencia, 스페인, 46014
- Hospital General Universitario de Valencia
-
-
Barcelona
-
L' Hospitalet de Llobregat, Barcelona, 스페인, 08907
- ICO (Institut Catalá d´Oncología)
-
Manresa, Barcelona, 스페인, 08243
- Fundació Althaia
-
Sabadell, Barcelona, 스페인, 08208
- Corporacio Sanitaria Parc Tauli
-
-
Madrid
-
Majadahonda, Madrid, 스페인, 28222
- Hospital Puerta de Hierro Majadahonda
-
-
-
-
-
Buenos Aires, 아르헨티나, C1181ACH
- Hospital Italiano de Buenos Aires
-
Buenos Aires, 아르헨티나, C1272AAA
- Hospital de Rehabilitación Respiratoria María Ferrer
-
Mendoza, 아르헨티나, M5500AYB
- COIR
-
Rosario, Santa Fe, 아르헨티나, S2001SBL
- Hospital Espanol de Rosario
-
Santa Fé, 아르헨티나, S3000FFU
- ISIS Centro Especializado De Luce S.A.
-
-
-
-
-
Birmingham, 영국, B9 5SS
- Birmingham Heartlands Hospital
-
Bristol, 영국, BS2 8ED
- Bristol Haematology and Oncology Centre
-
Dundee, 영국, DD1 9SY
- Ninewells Hospital
-
Glasgow, 영국, G12 0YN
- Beatson West of Scotland Cancer Centre
-
Guildford, 영국, GU2 7XX
- The Royal Surrey County Hospital NHS Trust
-
Lecester, 영국, LE1 5WW
- Leicester Royal Infirmary
-
Leeds, 영국, LS9 7TF
- St James' Institute of Oncology, Bexley Wing, St James' University Hospital
-
London, 영국, SE1 9RT
- Guy's Hospital
-
London, 영국, SW3 6JJ
- Royal Marsden Hospital
-
Sutton, 영국, SM2 5PT
- Royal Marsden Hospital
-
-
-
-
-
Innsbruck, 오스트리아, 6020
- Universitaetsklinikum Innsbruck
-
Linz, 오스트리아, 4021
- Allgemeines Krankenhaus der Stadt Linz
-
Salzburg, 오스트리아, 5020
- Landeskrankenhaus SalzburgUniversitaetsklinikum der PMUUniversitaetsklinik für Pneumologie
-
Wien, 오스트리아, 1130
- Krankenhaus Hietzing
-
Wien, 오스트리아, 1090
- AKH Wien
-
Wien, 오스트리아, 1140
- SMZ Baumgartner Hoehe - Otto Wagner Spital
-
Wien, 오스트리아, A-1140
- SMZ Baumgartner Höhe - Otto- Wagner-Spital
-
-
-
-
-
Ancona, 이탈리아, 60020
- Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I
-
Bologna, 이탈리아, 40139
- Ospedale Bellaria
-
Catania, 이탈리아, 95100
- Ospedale Garibaldi Nesima
-
Genova, 이탈리아, 16132
- Istituto Nazionale per la Ricerca e la Cura del Cancro
-
Parma, 이탈리아, 43100
- Azienda Ospedaliero- Universitaria di Parma
-
Perugia, 이탈리아, 06132
- Ospedale S. Maria Della Misericordia
-
Roma, 이탈리아, 00152
- Azienda Ospedaliera San Camillo Forlanini
-
-
-
-
-
Ceske Budejovice, 체코 공화국, 370 87
- Nemocnice České Budějovice, a.s.
-
Ostrava-Poruba, 체코 공화국, 70852
- Fakultni nemocnice OstravaKlinika tuberkulozy a respiracnich nemoci
-
Praha, 체코 공화국, 8 18081
- FN Bulovka Klinika plincni a hrrudni chirurgie
-
-
-
-
-
Toronto, 캐나다, M6R 1B5
- St. Joseph's Health Centre
-
-
Alberta
-
Edmonton, Alberta, 캐나다, T6G 1Z2
- Cross Cancer Institute
-
-
Ontario
-
Kingston, Ontario, 캐나다, K7L 5P9
- Cancer Center of Southeastern Ontario at Kingston General Hospital
-
Mississauga, Ontario, 캐나다, L5M 2N1
- Trillium Health Partners - Credit Valley Hospital
-
Newmarket, Ontario, 캐나다, L3Y 2P9
- Stronach Regional cancer Centre at Southlake
-
Oshawa, Ontario, 캐나다, L1G 2B9
- RS MacLaughlin Durham Regional Cancer Centre
-
Sault Ste Marie, Ontario, 캐나다, P6A 5K7
- Sault Area Hospital
-
Thunder Bay, Ontario, 캐나다, P7B 6V4
- Thunder Bay Regional Health Science Centre
-
Toronto, Ontario, 캐나다, M5G 2C4
- Toronto General Hospital
-
-
Quebec
-
Montreal, Quebec, 캐나다, H3A 1A1
- Royal Victoria Hospital
-
Montreal, Quebec, 캐나다, H3G 1A4
- Montreal General Hospital
-
Montreal, Quebec, 캐나다, H2W 1S6
- McGill Dept. of Oncology
-
-
-
-
-
Lublin, 폴란드, 20-954
- Samodzielny Publiczny Szpital Kliniczny nr 4
-
Otwock, 폴란드, 05-400
- Mazowieckie Centrum Leczenia Chorob Pluc I Gruzlicy
-
Poznan, 폴란드, 60-569
- Wielkoposkie Centrum Pulmonologii i Torakochirurgii, Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii
-
Szczecin, 폴란드, 70-891
- Specjalistyczny Szpital im. prof.Alfreda Sokolowskiego
-
Warsaw, 폴란드, 02-781
- Centrum Onkologii - Instytut im. Marii Skllodowskiej - Curie
-
Wroclaw, 폴란드, 53-439
- Dolnoslaskie Centrum Chorob Pluc we Wroclawiu, Katedra i Klinika Pulmonologii i Nowotworow Pluc Akademii Medycznej
-
-
-
-
-
Bayonne, 프랑스, 64100
- Centre d'Oncologie et de Radiotherapie du pays Basque
-
Brest cedex, 프랑스, 29609
- C.H.U. Morvan, Institut de Cancerologie et d'Hématologie
-
Caen Cedex, 프랑스, 14033
- CHU de Caen - Service de pneumologie
-
Clermont-Ferrand cedex 1, 프랑스, 63003
- CHU Clermont Ferrand - Hôpital Gabriel Montpied - Service de pneumologie
-
Lyon cedex 04, 프랑스, 69317
- Hopital De La Croix-Rousse Service de Pneumologie
-
Marseille cedex 9, 프랑스, 13273
- Institut Paoli-Calmettes
-
PARIS cedex 14, 프랑스, 75014
- Fondation Hopital Saint Joseph
-
Paris, 프랑스, 75012
- Hôpital de Tenon
-
Perpignan, 프랑스, 66000
- Centre Catalan d'Oncologie
-
Rennes cedex 9, 프랑스, 35033
- CHU - Hopital Pontchaillou - Service de pneumologie
-
Saint Priest en Jarez, 프랑스, 42271
- Institut de Cancérologie de la Loire
-
Vandoeuvre-lès-Nancy Cedex, 프랑스, 54511
- Hôpital de Brabois
-
-
Cedex 9
-
Toulouse, Cedex 9, 프랑스, 31059
- CHU Larrey Service de Pneumologie, Clinique des voies respiratoires
-
-
-
-
-
Budapest, 헝가리, 1121
- Orszagos Koranyi Tbc es Pulmonologiai Intezet
-
Budapest, 헝가리, 1125
- Semmelweis Egyetem Altalanos Orvostudományi Kar Pulmonologiai Klinika
-
Deszk, 헝가리, 6772
- Csongrad Megyei Onkormanyzat, Mellkasi Betegsegek Szakkorhaza
-
Pécs, 헝가리, 7623
- Pecsi Tudomany Egyete m Klinikai Kozpont, I.sz Belgyogyaszati Klinika Pulmonologiai Munkacsoport
-
Szekesfehervar, 헝가리, 8000
- Fejer Megyei Szent Gyorgy Korhaz
-
Szombathely, 헝가리, 9700
- Vas Megyei Markusovszky Lajos Altalanos Rehabilitacios es Gyogyfurdo Korhaz, Egyetemi Oktatoko Zarkoruen Mukodo Nonprofit Reszveny Tarsasag
-
-
-
-
-
Adelaide, 호주, 5067
- Respiratory Clinical Trials Pty., Ltd
-
Ashford, 호주, SA 5037
- Ashford Cancer Centre
-
-
New South Wales
-
Campbelltown, New South Wales, 호주, 2560
- Campbelltown Hospital
-
Liverpool, New South Wales, 호주, 2170
- Liverpool Hospital
-
St Leonards, New South Wales, 호주, 2065
- Royal North Shore Hospital
-
-
Victoria
-
East Bentleigh, Victoria, 호주, 3165
- Monash Medical Centre
-
Fitzroy, Victoria, 호주, 3065
- St Vincent's Hospital Melbourne
-
Heidelberg, Victoria, 호주, 3084
- Austin Hospital
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Primary tissue from patient's surgery must be epidermal growth factor receptor (EGFR)-positive by certain tests
- Patients may have up to 4 cycles of chemotherapy after surgery
- Complete removal of the tumor by surgery
Able to start drug under the following timelines:
- 6 months from the day of surgery for patients who get chemotherapy
- 3 months from the day of surgery for those who do not get chemotherapy
- Confirmed diagnosis of Stage IB-IIIA NSCLC
- Patients must be accessible for follow-up visits
Exclusion Criteria:
- History of prior radiotherapy for NSCLC either before or after surgery
- History of heart disease or uncontrolled heart arrhythmias within the previous year
- History of poorly controlled gastrointestinal (GI) disorders that could affect the absorption of study drug
- History of other cancer except certain skin or cervical cancers, patients who have had other cancer are eligible if they have remained disease free for at least 5 years
- Patients who have received chemotherapy for NSCLC before surgery
- Tumors with mixed histology of NSCLC and Small Cell Lung Cancer (SCLC). Patients with carcinoid tumors are not eligible.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 네 배로
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Erlotinib
Participants received 150 mg/day erlotinib orally for 2 years or until relapse, death, participant request or investigator decision to discontinue study drug, or intolerable toxicity.
|
150 mg tablet
다른 이름들:
|
|
위약 비교기: Placebo
Participants received matching placebo tablets orally for 2 years or until relapse, death, participant request or investigator decision to discontinue study drug, or intolerable toxicity.
|
위약 정제
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Disease Free Survival (DFS)
기간: Every 3 months during active phase and every 6 months during long term follow-up up to 5 years and yearly thereafter until the data cut-off date of 08 April 2013 (maximum time on follow-up was 64 months).
|
DFS is the time from the date of randomization until the first day non-small cell lung cancer (NSCLC) relapse is documented by radiological exam and/or biopsy, or until death in the absence of relapse.
After randomization, NSCLC relapse was based on radiological evidence or biopsy, as determined by the investigator.
Participants without a DFS event were censored on the last adequate radiological assessment date.
|
Every 3 months during active phase and every 6 months during long term follow-up up to 5 years and yearly thereafter until the data cut-off date of 08 April 2013 (maximum time on follow-up was 64 months).
|
|
Disease Free Survival (DFS)
기간: Every 3 months during active phase and every 6 months during long term follow-up up to 5 years and yearly thereafter until the data cutoff date of 11 June 2014 (maximum time on follow-up was 78 months).
|
DFS is the time from the date of randomization until the first day that non-small cell lung cancer (NSCLC) relapse is documented by radiological exam and/or biopsy, or until death in the absence of relapse.
After randomization, NSCLC relapse was based on radiological evidence or biopsy, as determined by the investigator.
Participants without a DFS event were censored on the last adequate radiological assessment date.
|
Every 3 months during active phase and every 6 months during long term follow-up up to 5 years and yearly thereafter until the data cutoff date of 11 June 2014 (maximum time on follow-up was 78 months).
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Overall Survival (OS)
기간: Every 3 months during active phase and every 6 months during long term follow-up up to 5 years and yearly thereafter until the data cut-off date of 08 April 2013 (maximum time on follow-up was 64 months).
|
Overall survival was defined as the time from the date of randomization until the documented date of death.
Participants who were still alive were censored on the last day they were known to be alive.
|
Every 3 months during active phase and every 6 months during long term follow-up up to 5 years and yearly thereafter until the data cut-off date of 08 April 2013 (maximum time on follow-up was 64 months).
|
|
Overall Survival (OS)
기간: Every 3 months during active phase and every 6 months during long term follow-up up to 5 years and yearly thereafter until the data cut-off date of 11 June 2014 (maximum time on follow-up was 78 months).
|
Overall survival was defined as the time from the date of randomization until the documented date of death.
Participants who were still alive were censored on the last day they were known to be alive.
|
Every 3 months during active phase and every 6 months during long term follow-up up to 5 years and yearly thereafter until the data cut-off date of 11 June 2014 (maximum time on follow-up was 78 months).
|
|
Disease-free Survival in Participants With EGFR Mutation - Positive Tumors
기간: Every 3 months during active phase and every 6 months during long term follow-up up to 5 years and yearly thereafter until the data cut-off date of 08 April 2013 (maximum time on follow-up was 64 months).
|
Disease-free survival (DFS) is the time from the date of randomization until the first day NSCLC relapse is documented by radiological exam and/or biopsy, or until death in the absence of relapse.
After randomization, NSCLC relapse was based on radiological evidence or biopsy, as determined by the investigator.
Participants without a DFS event were censored on the last adequate radiological assessment date.
Activating EGFR mutation-positive is defined as exon 19 deletion or exon 21 L858R (or both) detected.
|
Every 3 months during active phase and every 6 months during long term follow-up up to 5 years and yearly thereafter until the data cut-off date of 08 April 2013 (maximum time on follow-up was 64 months).
|
|
Disease-free Survival in Participants With EGFR Mutation - Positive Tumors
기간: Every 3 months during active phase and every 6 months during long term follow-up up to 5 years and yearly thereafter until the data cut-off date of 11 June 2014 (maximum time on follow-up was 78 months).
|
Disease-free survival (DFS) is the time from the date of randomization until the first day NSCLC relapse is documented by radiological exam and/or biopsy, or until death in the absence of relapse.
After randomization, NSCLC relapse was based on radiological evidence or biopsy, as determined by the investigator.
Participants without a DFS event were censored on the last adequate radiological assessment date.
Activating EGFR mutation-positive is defined as exon 19 deletion or exon 21 L858R (or both) detected.
|
Every 3 months during active phase and every 6 months during long term follow-up up to 5 years and yearly thereafter until the data cut-off date of 11 June 2014 (maximum time on follow-up was 78 months).
|
|
Overall Survival in Participants With EGFR Mutation - Positive Tumors
기간: Every 3 months during active phase and every 6 months during long term follow-up up to 5 years and yearly thereafter until the data cut-off date of 08 April 2013 (maximum time on follow-up was 64 months)
|
Overall survival is defined as the time from the date of randomization until the documented date of death. Participants who were still alive were censored on the last day they were known to be alive. Activating EGFR mutation-positive is defined as exon 19 deletion or exon 21 L858R (or both) detected. |
Every 3 months during active phase and every 6 months during long term follow-up up to 5 years and yearly thereafter until the data cut-off date of 08 April 2013 (maximum time on follow-up was 64 months)
|
|
Overall Survival in Participants With EGFR Mutation - Positive Tumors
기간: Every 3 months during active phase and every 6 months during long term follow-up up to 5 years and yearly thereafter until the data cut-off date of 11 June 2014 (maximum time on follow-up was 78 months)
|
Overall survival is defined as the time from the date of randomization until the documented date of death. Participants who were still alive were censored on the last day they were known to be alive. Activating EGFR mutation-positive is defined as exon 19 deletion or exon 21 L858R (or both) detected. |
Every 3 months during active phase and every 6 months during long term follow-up up to 5 years and yearly thereafter until the data cut-off date of 11 June 2014 (maximum time on follow-up was 78 months)
|
|
Number of Participants With Adverse Events (AEs)
기간: From the date of first dose of study drug until 30 days after the last dose. The median time on treatment was 11.9 months for erlotinib and 21.9 months for placebo. Data are based off the 11 June 2014 data cut-off date.
|
An AE was defined as any untoward medical occurrence in a study participant and did not necessarily have a causal relationship with study treatment. An AE was considered serious if it resulted in death, a life-threatening situation, inpatient hospitalization or prolongation of existing hospitalization, persistent or significant disability/incapacity, congenital anomaly/birth defect in the offspring of a participant, other important medical events, or is on the Astellas Always Serious List. A drug-related AE was any AE with at least a possible relationship to study treatment as assessed by the investigator. Severity was graded by the investigator according to the National Cancer Institute Common Terminology Criteria for Adverse Events, v3.0, where Grade 1=Mild AE; Grade=2 Moderate AE; Grade 3=Severe AE; Grade 4=Life-threatening or disabling; Grade 5=Death related to AE. AEs leading to death include deaths that occurred more than 30 days after the last dose of study drug. |
From the date of first dose of study drug until 30 days after the last dose. The median time on treatment was 11.9 months for erlotinib and 21.9 months for placebo. Data are based off the 11 June 2014 data cut-off date.
|
공동 작업자 및 조사자
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
키워드
추가 관련 MeSH 약관
기타 연구 ID 번호
- OSI-774-302
- 2005-001747-29 (EudraCT 번호)
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .